miR-126 negatively regulates insulin receptor substrate 1 (IRS-1), Kristen rat sarcoma viral oncogene (KRAS), and GATA binding protein 4 (GATA4) and its loss is implicated in tumor progression. The gene discussed is IRS1; the disease is neoplasm.